CWAS-Plus: Estimating category-wide association of rare noncoding variation from whole-genome sequencing data with cell-type-specific functional data
Yujin KimiD, Minwoo Jeong, In Gyeong KohiD, Chanhee KimiD, Hyeji LeeiD, Jae Hyun KimiD, Ronald YurkoiD, Il Bin KimiD, Jeongbin ParkiD, Donna M. WerlingiD, Stephan SandersiD, Joon‐Yong AniD
Abstract
Variants in cis-regulatory elements link the noncoding genome to human brain pathology; however, detailed analytic tools for understanding the association between cell-level brain pathology and noncoding variants are lacking. CWAS-Plus, adapted from a Python package for category-wide association testing (CWAS) employs both whole-genome sequencing and user-provided functional data to enhance noncoding variant analysis, with a faster and more efficient execution of the CWAS workflow. Here, we used single-nuclei assay for transposase-accessible chromatin with sequencing to facilitate CWAS-guided noncoding variant analysis at cell-type specific enhancers and promoters. Examining autism spectrum disorder whole-genome sequencing data (n = 7,280), CWAS-Plus identified noncoding de novo variant associations in transcription factor binding sites within conserved loci. Independently, in Alzheimers disease whole-genome sequencing data (n = 1,087), CWAS-Plus detected rare noncoding variant associations in microglia-specific regulatory elements. These findings highlight CWAS-Pluss utility in genomic disorders and scalability for processing large-scale whole-genome sequencing data and in multiple-testing corrections. CWAS-Plus and its user manual are available at https://github.com/joonan-lab/cwas/ and https://cwas-plus.readthedocs.io/en/latest/, respectively. KEY POINTSO_LICWAS-Plus efficiently identifies noncoding associations in WGS data, supporting user-friendly categorization and burden enrichment tests. C_LIO_LICWAS-Plus integrates various functional datasets, emphasizing cell-type-specific noncoding associations. C_LIO_LICWAS-Plus provides a novel approach for multiple testing correction, enhancing the reliability of the results. C_LIO_LIAutism spectrum disorder risk noncoding variants are identified as enriched with transcription factors, suggesting their role in the pathology. C_LIO_LIRare variant analysis with Alzheimers disease samples reveals strong association with microglia, supporting the reliability of the results produced by CWAS-Plus. C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 17
- FWCI
- 4.78
- Field percentile
- top 4%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Identifying associations of de novo noncoding variants with autism through integration of gene expression, sequence and sex information
Runjia Li, Jason Ernst·Genome biologyPeer-reviewed·Jun 4, 2025
- ENCODE guided WGS analysis can identify trait associated regulatory regions driven by rare-variants
Jack Thomas Flanagan, Kisung Nam, Seung‐Geun Lee·medRxiv·Nov 6, 2024
- Limited contribution of rare, noncoding variation to autism spectrum disorder from sequencing of 2,076 genomes in quartet families
Donna M. Werling, Harrison Brand, … Stephan Sanders·European NeuropsychopharmacologyPeer-reviewed·Jan 1, 2019
- Key variants via Alzheimer's Disease Sequencing Project whole genome sequence data
Yanbing Wang, Chloé Sarnowski, … for the Alzheimer's Disease Sequencing Project (ADSP)·Alzheimer s & DementiaPeer-reviewed·Mar 21, 2024
- Modeling cis-regulatory variation in human brain enhancers across a large Parkinson's Disease cohort
Olga M. Sigalova, Alexandra Pančíková, … Stein Aerts·bioRxiv·Apr 16, 2026
- Whole-genome sequencing reveals new Alzheimer's disease-associated rare variants in loci related to synaptic function and neuronal development
Dmitry Prokopenko, Sarah L. Morgan, … Rudolph E. Tanzi·Alzheimer s & DementiaPeer-reviewed·Apr 2, 2021